Arguing over the meaning of terms such as "could" and "might" is a useful delaying tactic, too.
The status doesn't prevent conversion or demolition, but it gives the community a right to bid to buy the site if it comes up for sale, triggering a moratorium of six months to help them raise funds, a useful delaying tactic which is often enough to deter potential developers.
Waiting a bit, writes the amiable law-and-finance-prof author, is usually a good idea: he discusses useful delays in the expert actions of fighter pilots, sportspeople and doctors; how comedians place a "beat"; why a "snap apology" can be a bad idea; and how a high-frequency stock-trading system (exploiting the mysteries of fibre-optic cable) got better results when forced to slow down.
"Most of us would have preferred a stronger agreement," the letter begins, going on to assess the proposed accord as useful for delaying Iran's program, but not a long-term solution to the problem of a nuclear Iran.
Rotation of fipronil with other insecticides having no cross resistance should be useful for delaying the development of resistance in M. domestica.
ICSM35 binds residues 91 and 110 on the N-terminal region of the truncated PrP27 30 and was shown to be useful in delaying disease onset albeit leading to incomplete inhibition of PrPSc replication in the spleen of scrapie-infected mice [14], [33].
Given that inflammation is present from onset, anti-inflammatory drugs such as corticosteroids could prove useful for delaying impairment of lung function in the long term.
To overcome the cardiotoxic effect of anthracyclines the use of antioxidants have been suggested [ 38, 39], however antioxidants has proven to be useful in delaying or preventing chronic cardiotoxicity in rodents [ 40] but not in dogs [ 41] or sheep [ 42].
Not only could dasatinib provide a much needed treatment option for patients with imatinib-resistant CML, but also, combined with imatinib, it might prove to be useful in delaying the onset of resistance seen with imatinib monotherapy.
Although dasatinib is still in the early stages of development, the potential impact of this molecule on the treatment of CML could be revolutionary, not only providing a much needed treatment option for patients with imatinib-resistant CML, but also, combined with imatinib, could possibly prove useful in delaying the onset of resistance to treatment.
It is particularly useful for delayed symptoms.
